Nike MD - Tempus AI, Senior Pathology
| TEM Stock | 62.59 0.39 0.62% |
Executive
Nike MD is Senior Pathology of Tempus AI, Class
| Address | 600 West Chicago Avenue, Chicago, IL, United States, 60654 |
| Phone | 800 976 5448 |
| Web | https://www.tempus.com |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Claudio Morales | Grupo Aeroportuario del | 73 | |
| Jane Daniel | Aegon NV ADR | N/A | |
| Michael II | Mesa Air Group | N/A | |
| Jan Weidema | Aegon NV ADR | N/A | |
| Margaret Tooth | Trupanion | 45 | |
| Dona Young | Aegon NV ADR | 66 | |
| Mark Ellman | Aegon NV ADR | 64 | |
| Marc Weede | Aegon NV ADR | 58 | |
| Jeffrey Lange | Old Republic International | 53 | |
| Caroline Ramsay | Aegon NV ADR | 59 | |
| Kristine CFA | Westinghouse Air Brake | 48 | |
| Alejandro Lopez | Grupo Aeroportuario del | 58 | |
| Manuel Sola | Grupo Aeroportuario del | 61 | |
| Shawn McWashington | Trupanion | N/A | |
| Michael Ferverda | Mesa Air Group | 80 | |
| Carla Mahieu | Aegon NV ADR | 61 | |
| David CPA | Citizens | 60 | |
| Kivin Jones | Old Republic International | N/A | |
| MRCVS BVMS | Trupanion | 49 | |
| Thomas Wellauer | Aegon NV ADR | 66 | |
| Doug Cooper | Mesa Air Group | N/A | |
Tempus AI, Class Leadership Team
Elected by the shareholders, the Tempus AI,'s board of directors comprises two types of representatives: Tempus AI, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tempus. The board's role is to monitor Tempus AI,'s management team and ensure that shareholders' interests are well served. Tempus AI,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tempus AI,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eric Lefkofsky, CEO, CoFounder | ||
| Ryan Fukushima, Chief Officer | ||
| Stacey Kraft, Chief Officer | ||
| Shane Colley, Chief Officer | ||
| James Rogers, Chief Officer | ||
| Kate Sasser, Chief Officer | ||
| Patty Spiller, Senior Marketing | ||
| Nike MD, Senior Pathology | ||
| Christina Antoniou, Senior Development | ||
| Ryan Bartolucci, Chief Officer | ||
| Ryan CPA, Chief Officer | ||
| Erik Phelps, Assistant VP |
Tempus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tempus AI, a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Profit Margin | (1.21) % | ||||
| Operating Margin | (3.21) % | ||||
| Current Valuation | 7.9 B | ||||
| Shares Outstanding | 149.28 M | ||||
| Shares Owned By Insiders | 63.70 % | ||||
| Shares Owned By Institutions | 27.61 % | ||||
| Number Of Shares Shorted | 4.18 M | ||||
| Price To Book | 80.57 X | ||||
| Price To Sales | 13.29 X | ||||
| Revenue | 531.82 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Tempus AI, Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tempus AI,. If investors know Tempus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tempus AI, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.55) | Revenue Per Share 8.74 | Quarterly Revenue Growth 0.253 |
The market value of Tempus AI, Class is measured differently than its book value, which is the value of Tempus that is recorded on the company's balance sheet. Investors also form their own opinion of Tempus AI,'s value that differs from its market value or its book value, called intrinsic value, which is Tempus AI,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tempus AI,'s market value can be influenced by many factors that don't directly affect Tempus AI,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tempus AI,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Tempus AI, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tempus AI,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.